A recently published study shines a light on a peculiar quirk of the Medicare Part D benefit structure: For some high-priced specialty medications, seniors might pay less out-of-pocket for brand-name drugs than their generic counterparts.A leader from one Medicare-focused insurer tells AIS Health that while the issue doesn’t affect a very large swath of members, it’s still worth addressing.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.